Plainly and simply, biotech is where the money is flowing.
Why?
Because in a slow growth environment, high growth can always be had in the business of death. Look at the oil barrel sector: getting lit up in the face of a flamboyantly proud rally. We are seeing a divergence between crazed faced oil stocks and everything else. The energy trade, for now, is in the ‘fag box‘. Look at SLCA, EMES, FMSA and HCLP; they’re trading as if it was the end of the world. Surely there is opportunity to be had in this wanton liquidation, no? I’d love to muster the courage to triple my SLCA position here. But I already have big positions in both TRN and CLR.
No, I am convinced the path to prosperity is through drugs. The only issue with the drug stocks is valuation. So many of them are up 20-50% in recent months. One that I am long, which is still reasonably prized, is JAZZ. People are sleeping on this one (pun intended).
In summary, oil focused hedge funds are being dismantled and tossed into the meat grinder. Everything else seems A-okay–for now.
Comments »
